These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 30077416)
1. Preferential interaction of MHC class I with TAPBPR in the absence of glycosylation. Neerincx A; Boyle LH Mol Immunol; 2019 Sep; 113():58-66. PubMed ID: 30077416 [TBL] [Abstract][Full Text] [Related]
2. Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway. Boyle LH; Hermann C; Boname JM; Porter KM; Patel PA; Burr ML; Duncan LM; Harbour ME; Rhodes DA; Skjødt K; Lehner PJ; Trowsdale J Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3465-70. PubMed ID: 23401559 [TBL] [Abstract][Full Text] [Related]
3. The glycosylation status of MHC class I molecules impacts their interactions with TAPBPR. Ilca FT; Boyle LH Mol Immunol; 2021 Nov; 139():168-176. PubMed ID: 34543843 [TBL] [Abstract][Full Text] [Related]
4. The binding of TAPBPR and Tapasin to MHC class I is mutually exclusive. Hermann C; Strittmatter LM; Deane JE; Boyle LH J Immunol; 2013 Dec; 191(11):5743-50. PubMed ID: 24163410 [TBL] [Abstract][Full Text] [Related]
5. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Hughes EA; Cresswell P Curr Biol; 1998 Jun; 8(12):709-12. PubMed ID: 9637923 [TBL] [Abstract][Full Text] [Related]
6. TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst. Hermann C; van Hateren A; Trautwein N; Neerincx A; Duriez PJ; Stevanović S; Trowsdale J; Deane JE; Elliott T; Boyle LH Elife; 2015 Oct; 4():. PubMed ID: 26439010 [TBL] [Abstract][Full Text] [Related]
7. Structural and dynamic studies of TAPBPR and Tapasin reveal the mechanism of peptide loading of MHC-I molecules. Margulies DH; Jiang J; Natarajan K Curr Opin Immunol; 2020 Jun; 64():71-79. PubMed ID: 32402827 [TBL] [Abstract][Full Text] [Related]
8. TAPBPR bridges UDP-glucose:glycoprotein glucosyltransferase 1 onto MHC class I to provide quality control in the antigen presentation pathway. Neerincx A; Hermann C; Antrobus R; van Hateren A; Cao H; Trautwein N; Stevanović S; Elliott T; Deane JE; Boyle LH Elife; 2017 Apr; 6():. PubMed ID: 28425917 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of function of tapasin, a critical major histocompatibility complex class I assembly factor. Rizvi SM; Raghavan M Traffic; 2010 Mar; 11(3):332-47. PubMed ID: 20070606 [TBL] [Abstract][Full Text] [Related]
10. Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomes. van Hateren A; Elliott T Curr Opin Immunol; 2023 Aug; 83():102340. PubMed ID: 37245412 [TBL] [Abstract][Full Text] [Related]
11. TAPBPR: a new player in the MHC class I presentation pathway. Hermann C; Trowsdale J; Boyle LH Tissue Antigens; 2015 Mar; 85(3):155-66. PubMed ID: 25720504 [TBL] [Abstract][Full Text] [Related]
12. A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum. Diedrich G; Bangia N; Pan M; Cresswell P J Immunol; 2001 Feb; 166(3):1703-9. PubMed ID: 11160214 [TBL] [Abstract][Full Text] [Related]
13. Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR. Ilca FT; Drexhage LZ; Brewin G; Peacock S; Boyle LH Cell Rep; 2019 Nov; 29(6):1621-1632.e3. PubMed ID: 31693900 [TBL] [Abstract][Full Text] [Related]
14. The Ins and Outs of TAPBPR. Ilca T; Boyle LH Curr Opin Immunol; 2020 Jun; 64():146-151. PubMed ID: 32814254 [TBL] [Abstract][Full Text] [Related]
15. Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. Peaper DR; Wearsch PA; Cresswell P EMBO J; 2005 Oct; 24(20):3613-23. PubMed ID: 16193070 [TBL] [Abstract][Full Text] [Related]
16. TAPBPR mediates peptide dissociation from MHC class I using a leucine lever. Ilca FT; Neerincx A; Hermann C; Marcu A; Stevanović S; Deane JE; Boyle LH Elife; 2018 Nov; 7():. PubMed ID: 30484775 [TBL] [Abstract][Full Text] [Related]
17. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Wearsch PA; Cresswell P Nat Immunol; 2007 Aug; 8(8):873-81. PubMed ID: 17603487 [TBL] [Abstract][Full Text] [Related]
18. Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules. Ilca FT; Neerincx A; Wills MR; de la Roche M; Boyle LH Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9353-E9361. PubMed ID: 30213851 [TBL] [Abstract][Full Text] [Related]
19. The ER folding sensor UGGT1 acts on TAPBPR-chaperoned peptide-free MHC I. Sagert L; Winter C; Ruppert I; Zehetmaier M; Thomas C; Tampé R Elife; 2023 Jun; 12():. PubMed ID: 37345806 [TBL] [Abstract][Full Text] [Related]
20. Structure of the human MHC-I peptide-loading complex. Blees A; Januliene D; Hofmann T; Koller N; Schmidt C; Trowitzsch S; Moeller A; Tampé R Nature; 2017 Nov; 551(7681):525-528. PubMed ID: 29107940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]